Related Experiment Video
Updated: Jun 28, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Predicting treatment outcome in stimulant dependence.
Martina Reske1, Martin P Paulus
1Department of Psychiatry, University of California San Diego, La Jolla, CA92037-0985, USA.
Functional neuroimaging shows promise for predicting substance use disorder outcomes, but clinical heterogeneity and measurement approaches require careful consideration for optimal use.
Area of Science:
- Neuroscience
- Clinical Psychology
- Radiology
Background:
- Substance use disorders (SUDs) are complex and heterogeneous.
- Predicting SUD outcomes is crucial for effective treatment.
- Current predictive models have limitations.
Purpose of the Study:
- To review challenges in using functional neuroimaging for SUD outcome prediction.
- To discuss clinical heterogeneity and substance-type independence in SUDs.
- To explore functional magnetic resonance imaging (fMRI) applications in SUD research.
Main Methods:
- Literature review of functional neuroimaging in SUDs.
- Analysis of clinical heterogeneity and longitudinal course measurement.
- Discussion of outcome predictors and their limitations.
- Focus on fMRI-based outcome prediction.
Main Results:
- Clinical heterogeneity of SUDs impacts outcome prediction.
- SUD course is largely independent of substance type.
- Various methods exist for characterizing longitudinal SUD courses.
- Functional neuroimaging, particularly fMRI, offers potential predictive utility.
Conclusions:
- Optimizing functional neuroimaging for SUDs requires addressing heterogeneity.
- Standardized measurement of longitudinal SUD courses is needed.
- Further research and critical experiments are necessary to establish fMRI as a clinical tool for SUD outcome prediction.
More Related Videos
07:51A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Psychosis: Goals of Pharmacotherapy
Drug Dependence
Drug Therapy
Antianxiety Medications
Pharmacodynamic Models: Additive and Proportional Drug Effect Model